savepiginvest

savepiginvest

Ultimovacs is a norwegian clinical phase biotech with a universal cancer vaccine as its lead product. Today the company reported to the market that in march it will share topline data from its randomized phase 2 trial INITIUM for its lead product UV1 , a universal cancer vaccine to be used in combination with checkpoint inhibitors. The stock is at the...

savepiginvest Updated 

An average Q3 report for Photocure today giving some selling action, painting up the framework for a nice inverted head & shoulders formation within the long uptrend of the stock.

savepiginvest

Ultimovacs’ UV1 in combination with pembrolizumab shows 60% Objective Response Rate in advanced melanoma Phase I data • UV1/pembrolizumab results in 30% complete responses plus 30% partial responses • Good safety and tolerability profile supports use of UV1 in combination treatments • Data to be presented at ASCO and abstract to be discussed in webcast on May...

savepiginvest

AZTY reported sales of NOK 40.4 million (18.5) and an EBITDA of NOK 25.8 million (9.0) for the first quarter of 2021. Highlights from Q1 2021 · ArcticZymes Technologies (AZT) had Q1 sales of NOK 40.4 million growing by 119% (Q1 2020: NOK 18.5 million) · Coronavirus-related sales are estimated at NOK 16.5 million in Q1 2021 (NOK 3.8 million in Q1 2020) ·...

savepiginvest

Relentless buying of #PhysicalSilver causes a solid higher low to be set in the silver chart

savepiginvest Updated 

Photocure breaking free upwards from important 100 NOK resistance and heads for analyst BUY recommendations at 130+

savepiginvest

If the stock breaks through 50 day SMA it looks like it could start a nice bullish movement

savepiginvest

Almost like a machine, we seem to get repeated instances of these strong drops, followed by flat trading, and then a jump back up to the start level. I call this the reversed SEMI BART pattern, as it is not quite as flat and defined as we got used to seeing in Bitcoin, but still has some of the hallmarks of the pattern.

savepiginvest

SOFTOX HAS COMPLETED ENROLMENT OF SOFTOX WOUND IRRIGATION SOLUTION CONFIRMATORY STUDY (SWIS-02) SoftOx Solutions AS ("SoftOx") is pleased to announce that the enrolment of study participants for the clinical investigation «SWIS-02» has been completed. The study, which has been conducted at Bispebjerg University Hospital is a confirmatory clinical investigation...

savepiginvest Updated 

Nanovector ASA Nordic Nanovector - Q4’20 report: Pace of recruitment for PARADIGME picking up

savepiginvest

Kitron increases its 2025 revenue target from NOK 5 billion to NOK 6 billion. The company also raises its 2025 EBIT margin target from 7 to 8 percent.

savepiginvest Updated 

Silver may have a significant upside in 2021

savepiginvest

Delivery platform unicorn Glovo chooses StrongPoint as preferred supplier for grocery picking solutions StrongPoint today announces that Glovo, the on-demand meal and grocery delivery platform available in 22 countries and one of Europe’s leading technology unicorns (a valuation of over USD 1 billion), has chosen StrongPoint as a preferred supplier for grocery...

savepiginvest

What a time to be alive

savepiginvest

Photocure Partners with Asieris MediTech to Commercialize Hexvix in Mainland China and Taiwan Agreement Expands Photocure’s Hexvix®/Cysview® Franchise Footprint to over 30 Countries Oslo, Norway January 26, 2021, Photocure ASA (PHO:OSE): The Bladder Cancer Company focused on delivering transformative solutions to improve the lives of bladder cancer patients, ...

savepiginvest

Interesting to see Q4 report for ArcticZymes to learn more about the use of their cod enzymes in Covid 19 vaccines

savepiginvest

Biologics License Application for Narsoplimab in HSCT-TMA Accepted for Priority Review by U.S. FDA -- FDA sets PDUFA date of July 17, 2021 --

savepiginvest

Look for weekly close above 37